EGFR Testing Practices, Treatment Choice and Clinical Outcomes in Advanced NSCLC in a Real-World Setting

被引：0
|
作者：
Subramanian, J. [1 ]
Gregg, J. [2 ]
Berktas, M. [3 ]
Jiang, Z. [4 ]
Li, J. [4 ]
Taylor, A. [3 ]
Leighl, N. [5 ]
机构：
[1] St Lukes Canc Inst, Kansas City, MO USA
[2] Univ Calif Sacramento, Sacramento, CA USA
[3] AstraZeneca, Oncol Business Unit, Global Real World Evidence Sci, Cambridge, England
[4] AstraZeneca, Gaithersburg, MD USA
[5] Princess Margaret Canc Ctr, Med Oncol, Toronto, ON, Canada
来源：
JOURNAL OF THORACIC ONCOLOGY | 2022年 / 17卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
EP08.02-08
引用
收藏
页码：S438 / S439
页数：2
相关论文
共 50 条
  • [1] EGFR testing practices, treatment choice and clinical outcomes in advanced NSCLC in a real-world setting: A retrospective analysis of a US-based electronic health records database
    Subramanian, Janakiraman
    Gregg, Jeffrey
    Berktas, Mehmet
    Li, Jingyi
    Leighl, Natasha B.
    LUNG CANCER, 2025, 201
  • [2] Real-World treatment outcomes for advanced NSCLC in Greece
    Kokkotou, Eleni
    Stournara, Lamprini
    Mani, Maria
    Gkiozos, Ioannis
    Tsagouli, Sofia
    Syrigos, Nikolaos
    Burke, Thomas
    Desiniotis, Andreas
    Dimitriadis, Ioannis
    Charpidou, Andriani
    EUROPEAN RESPIRATORY JOURNAL, 2023, 62
  • [3] Real-world EGFR testing in patients with advanced EGFRm NSCLC in Belgium (REVEAL)
    Cuppens, K.
    Lodewyckx, L.
    Demedts, I.
    Decoster, L.
    Colinet, B.
    Deschepper, K.
    Janssens, A.
    Pauwels, P.
    Galdermans, D.
    Pieters, T.
    ANNALS OF ONCOLOGY, 2020, 31 : S1117 - S1117
  • [4] Real-world EGFR testing patterns among US patients with advanced NSCLC
    Vanderpoel, Julie
    Pericone, Chris
    He, Jinghua
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (28)
  • [5] Real-World Treatment Patterns and Clinical Outcomes in Advanced/Metastatic NSCLC Patients in England
    Verleger, Katharina
    Hertel, Nadine
    Solem, Caitlyn
    Penrod, John R.
    Macahilig, Cynthia
    Luo, Linlin
    Crawford, S. Michael
    BRITISH JOURNAL OF CANCER, 2018, 119 (11) : 5 - 5
  • [6] Outcomes of Anlotinib Maintenance Therapy in Patients With Advanced NSCLC in a Real-World Setting
    Li, Jia
    Han, Baohui
    Liu, Huaimin
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [7] Treatment patterns, duration and outcomes of pemetrexed maintenance therapy in patients with advanced NSCLC in a real-world setting
    Winfree, Katherine B.
    Torres, Aracelis Z.
    Zhu, Yajun Emily
    Muehlenbein, Catherine
    Aggarwal, Himani
    Woods, Susan
    Abernethy, Amy
    CURRENT MEDICAL RESEARCH AND OPINION, 2019, 35 (05) : 817 - 827
  • [8] PANORAMA - Real world molecular testing, treatment patterns, and clinical outcomes in patients with EGFR mutation-positive locally advanced or advanced NSCLC
    Griesinger, F.
    Buettner, R.
    Deppermann, K. -M.
    Reinmuth, N.
    Schuette, W.
    Thomas, M.
    Bergner, S.
    Schumann, C.
    ONCOLOGY RESEARCH AND TREATMENT, 2017, 40 : 248 - +
  • [9] Real-world treatment patterns, clinical outcomes and EGFR/T790M testing practices in patients with EGFRm advanced NSCLC and 1L EGFR TKI therapy: A retrospective multinational study (REFLECT)
    Addeo, A.
    Hochmair, M. J.
    Janzic, U.
    Dudnik, E.
    Charpidou, A.
    Pluzanski, A.
    Ciuleanu, T-E.
    Donev, I. Shterev
    Elbaz, J.
    Lupu, R.
    Ott, R. G.
    Peled, N.
    ANNALS OF ONCOLOGY, 2020, 31 : S840 - S840
  • [10] Afatinib in the treatment of advanced NSCLC with EGFR mutation: An observational real-world study.
    Li, Yun
    Wang, Xiaohua
    Wang, Li
    Kou, Yingying
    Ma, Xianglei
    Feng, Ji Feng
    Xiao, Mingzhe
    Shi, Meiqi
    Tang, Yiqun
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
12345